Production (Stage)
BioLife Solutions, Inc.
BLFS
$21.78
-$0.32-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -448.00K | 12.46M | -1.70M | -22.78M | -10.22M |
| Total Depreciation and Amortization | 1.38M | -1.47M | 2.32M | 2.44M | 2.28M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.55M | -10.21M | 5.41M | 24.15M | 6.11M |
| Change in Net Operating Assets | -3.76M | 857.00K | -1.22M | 2.64M | -2.64M |
| Cash from Operations | 1.73M | 1.65M | 4.80M | 6.46M | -4.48M |
| Capital Expenditure | -425.00K | -802.00K | -1.55M | 820.00K | -820.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -26.75M | 74.44M | -133.00K | -14.26M | 599.00K |
| Cash from Investing | -27.18M | 73.64M | -1.68M | -13.44M | -221.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.50M | -3.43M | -2.71M | 241.00K | -241.00K |
| Issuance of Common Stock | -- | 65.00K | 46.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -492.00K | -725.00K | 1.63M | -945.00K | -711.00K |
| Cash from Financing | -2.99M | -4.09M | -1.04M | -704.00K | -952.00K |
| Foreign Exchange rate Adjustments | -- | 29.00K | 36.00K | 0.00 | -65.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.44M | 71.23M | 2.12M | -7.68M | -5.71M |